Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy

  1. Manegold, C.
  2. Adjei, A.
  3. Bussolino, F.
  4. Cappuzzo, F.
  5. Crino, L.
  6. Dziadziuszko, R.
  7. Ettinger, D.
  8. Fennell, D.
  9. Kerr, K.
  10. Le Chevalier, T.
  11. Leighl, N.
  12. Papotti, M.
  13. Paz-Ares, L.
  14. Pérol, M.
  15. Peters, S.
  16. Pirker, R.
  17. Quoix, E.
  18. Reck, M.
  19. Smit, E.
  20. Vokes, E.
  21. Van Zandwijk, N.
  22. Zhou, C.
Zeitschrift:
ESMO Open

ISSN: 2059-7029

Datum der Publikation: 2016

Ausgabe: 1

Nummer: 6

Art: Rezension

DOI: 10.1136/ESMOOPEN-2016-000118 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus